Evaluating the technical feasibility of aflatoxin risk reduction strategies in Africa

Health economic impacts and cost-effectiveness of aflatoxin-reduction strategies in Africa: case studies in biocontrol and post-harvest interventions

(2010) F. Wu et al.   Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment

Sexual reproduction in Aspergillus flavus

(2009) Bruce W. Horn et al.   MYCOLOGIA

Aspergillus flavus: an emerging non-fumigatus Aspergillusspecies of significance

(2009) Suganthini Krishnan et al.   MYCOSES

Risks of Ingestion of Aflatoxin-Contaminated Groundnuts in Benin: Scale Measurements, Beliefs, and Socioeconomic Factors

(2009) C. M. Jolly et al.   RISK ANALYSIS

Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention

(2008) Lili Tang et al.   CARCINOGENESIS

Aflatoxin-Related Immune Dysfunction in Health and in Human Immunodeficiency Virus Disease

(2008) Yi Jiang et al.   Clinical & Developmental Immunology

Aflatoxin Exposure and Viral Hepatitis in the Etiology of Liver Cirrhosis in The Gambia, West Africa

(2008) Mark H. Kuniholm et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine

(2008) P. Wang et al.   Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment

Reducing human exposure to aflatoxin through the use of clay: A review

(2008) T. D. Phillips et al.   Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment

Risk assessment of aflatoxins in food in Africa

(2008) Gordon S. Shephard   Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment

High prevalence of hepatitis B virus among female sex workers in Nigeria

(2008) J. C. Forbi et al.   REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO

Immunotoxicity of aflatoxin B1: Impairment of the cell-mediated response to vaccine antigen and modulation of cytokine expression

(2008) Guylaine M. Meissonnier et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

COST-EFFECTIVENESS OF AFLATOXIN CONTROL METHODS: ECONOMIC INCENTIVES

(2008) Felicia Wu et al.   Toxin Reviews

Protective Interventions to Prevent Aflatoxin-Induced Carcinogenesis in Developing Countries

(2007) John D. Groopman et al.   Annual Review of Public Health